Garbutt J M, Ventrapragada M, Littenberg B, Mundy L M
Division of General Medical Sciences, Washington University School of Medicine, St. Louis, MO 63110, USA.
Clin Infect Dis. 2000 Mar;30(3):466-72. doi: 10.1086/313694.
We conducted a retrospective cohort study to determine the association between resistance to vancomycin and mortality among hospitalized patients with Enterococcus faecium bacteremia. We compared outcomes for patients infected with vancomycin-resistant versus vancomycin-susceptible E. faecium among 69 patients with bacteremia defined according to the National Nosocomial Infections Surveillance system. The univariate odds ratio (OR) for death associated with vancomycin resistance was 2.1 (P=.172). After controlling for severity of illness, we found that vancomycin resistance was not associated with mortality (OR, 1.74; 95% confidence interval, 0.5-6.12; P=.39). Vancomycin resistance does not independently increase mortality among patients with E. faecium bacteremia.
我们进行了一项回顾性队列研究,以确定粪肠球菌血症住院患者中对万古霉素的耐药性与死亡率之间的关联。在根据国家医院感染监测系统定义的69例菌血症患者中,我们比较了感染耐万古霉素粪肠球菌与对万古霉素敏感粪肠球菌患者的结局。与万古霉素耐药相关的死亡单因素比值比(OR)为2.1(P = 0.172)。在控制疾病严重程度后,我们发现万古霉素耐药与死亡率无关(OR,1.74;95%置信区间,0.5 - 6.12;P = 0.39)。万古霉素耐药并不会独立增加粪肠球菌血症患者的死亡率。